|Videos|August 4, 2021
Integrated Early Phase to Commercial Drug Substance to Drug Product
Author(s)Lonza
In this 15-minute talk, David K. Lyon, PhD, Senior Fellow of Research, Lonza, discusses a flexible, integrated model supporting over 600 small molecule therapies.
Related Content
Trending on Pharmaceutical Technology
1
Engineering High-Speed Pen Injector Final Assembly Machine: Solving the Cartridge Press-Fit Challenge
2
Using Automation to Enhance Pharmaceutical Manufacturing
3
Hidden Cost Drivers in Oligonucleotide Manufacturing
4
FDA Activity Round Up – July 2026
5